In RA, activated immune and stromal cells secrete high levels of RANKL, TNF-α, IL-1β, and IL-6, which drive excessive osteoclastogenesis through amplification of NF-κB, MAPK, and JAK-STAT signaling. The gene discussed is IL6; the disease is rheumatoid arthritis.